Strides Inc. recalls Strides Pharma Inc.Potassium Chloride Extended-Release Tablets, USP 8mEq (600 mg) 100 Tablets Rx Only Manufactured by:…
- Recall date
- August 24, 2020
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0001-2021
- FDA classification
- Class II
- Brand / firm
- Strides Inc.
- Sold / distributed
- nationwide
Why it was recalled
Failed Dissolution Specifications
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Strides Pharma Inc.Potassium Chloride Extended-Release Tablets, USP 8mEq (600 mg) 100 Tablets Rx Only Manufactured by: Strides Pharma Science Limited Bengaluru -562106 India Distributed by: Strides Pharma Inc., East Brunswick NJ 08816 NDC 64380-860-06
Get recall alerts
Free email alert whenever Strides Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Strides Inc.